CRVS vs TWLO · $1.04B cap vs P/E 1087, rev $2.91B
Corvus Pharmaceuticals Inc (CRVS) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Corvus Pharmaceuticals Inc (CRVS) is a biotechnology company listed on US.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
CRVS does not have a complete income-statement cache yet.
Latest reported TWLO revenue for 2026-06-30 was $2.91B. Net income was $1.16B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
CRVS currently screens at market cap $1.04B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the CRVS and TWLO stock pages for the full models.
Not investment advice.